All Articles

The B2B tech world is shifting. Generalist PR is out, and deep specialization is in. How one agency's growth reveals the future of tech communication.

Amylyx reveals positive initial safety data for its new ALS drug, AMX0114, a critical step as the firm aims to rebuild after the Relyvrio withdrawal.

Headwater Science's appointment of Susan Barnes isn't just a new hire; it's a strategic move to build the operational engine for regulatory-grade AI.

With its key project stalled, Lithium Ionic's appointment of a regulatory expert is a calculated move to navigate Brazil's complex mining landscape.

Denodo's 'One to Watch' status in Snowflake's latest report signals a new era where autonomous AI agents, fueled by governed data, redefine marketing.

Great Hill Partners' investment in Woof Gang signals a new era for the pet care industry, fueling a franchise powerhouse in a multi-billion dollar market.

New partnerships with CVMA and AMVQ offer tailored insurance to combat rising costs and burnout, a key move in Western Financial Group's national growth plan.

A new KKR-backed platform is betting big on turning game-day venues into year-round mega-districts, starting in Knoxville. It’s a multi-billion-dollar playbook.

An FDA fast-track for a devastating brain disease drug is a beacon of hope for patients and a major validation of Alphabet's long-term biotech strategy.

A new partnership between AGEPHA Pharma and Close-Up Intl reveals how AI is not just a buzzword, but a critical tool for getting vital medicines to patients.

In a head-to-head battle, Takeda's zasocitinib showed superior skin clearance over a key competitor, signaling a potential new standard for oral therapy.

With 100,000 clinicians in 15 months, Marit Health is using AI and peer data to tackle physician burnout, reshaping how doctors manage their careers.

Contango Silver & Gold accelerates work on three key projects, but its most critical challenge may not be in the ground, but in navigating markets and regulations.

PortugalFoods is bringing its premium F&B to NYC, using a Cristiano Ronaldo-backed venue to launch a new offensive in the competitive American market.

Bacardi now wholly owns Teeling Irish Whiskey. This isn't just another buyout; it's a new model for how industry giants can acquire and amplify craft soul.

A Canadian firm's compact satellite is set to map the Moon's treacherous South Pole for the ESA, proving that the future of deep space exploration is smaller, smarter, and more collaborative.

The federal government is funding two strategic projects in Hamilton aimed at preventing child abuse through systemic reform and culturally-led parenting programs.

A new survey finds 82% of travelers will overpay to avoid money arguments on group trips. It's a 'Peace Tax' that's costing relationships and budgets.

With a promising drug, fresh cash, and a new board member known for billion-dollar exits, Avalo Therapeutics is signaling a major strategic shift.

After a record stock plunge, Accenture's massive share buyback isn't just a financial defense—it's a defiant declaration of its AI-fueled future.